|4Jan 22, 5:21 PM ET

Cahill Brian Joseph 4

4 · EAGLE PHARMACEUTICALS, INC. · Filed Jan 22, 2021

Insider Transaction Report

Form 4
Period: 2020-12-18
Cahill Brian Joseph
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2020-12-18+5,00019,303 total
  • Award

    Employee Stock Option (Right to Buy)

    2020-12-18+10,00010,000 total
    Exercise: $48.09Exp: 2030-12-18Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]Represents restricted stock units ("RSUs"). The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the one, two, three and four-year anniversaries of December 18, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]The option vests over a period of four years, with 25% of the shares underlying the option vesting on October 29, 2021, and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION